Author

Alex Smith

Observed names: A.M. Smith, A.M.J. Smith

Observed institutions: University of Leeds, Trinity Health Michigan, Fondazione Humanitas per la Ricerca, IRCCS Humanitas Research Hospital, University College London, University of York

OpenAlex ID: A5110084290

The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population‐based haematological malignancy research network 2004‐2018

2021 · Stephen J. Richards, Daniel Painter, et al. · European Journal Of Haematology · 72

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)

2016 · Jinlei Li, Alex Smith, et al. · Cancer Causes & Control · 58

NCRN CLL207 Study of Alemtuzumab Consolidation In CLL: Final Response Assessment and Early Follow-up (on Behalf of the NCRI CLL Trials Sub-Group)

2010 · Abraham M Varghese, Dena Cohen, et al. · Blood · 6

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

2013 · Peter Hillmen, Donald Milligan, et al. · Blood · 4

Antihypertensive and anti-anginal drugs

1996 · G.D. Johnston, A.M.J. Smith · Elsevier eBooks · 1

PA-335 Overall Survival in Multiple Myeloma is Improving but Rates of Attrition Remain Unchanged

2026 · Christopher Parrish, Frances Seymour, et al. · Clinical Lymphoma Myeloma & Leukemia

PA-249 Improving Real-World Outcomes in the Frail and Elderly With Myeloma: Data From the UK Haematological Malignancy Research Network

2026 · Frances Seymour, Timothy Bagguley, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1041: Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

2026 · Sanjay Chanda, Alex Smith, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1076: Hematologic and Safety Profile of Epetraborole in a Non-Polycythemia Vera Patient Population

2026 · George H Talbot, Stanton Gerson, et al. · Clinical Lymphoma Myeloma & Leukemia

MPN-1082: Exposure-Response Analyses of Hemoglobin Changes During Epetraborole Administration to Nonhuman Primates Predict Human Exposure-Response Relationships

2026 · Christopher M Rubino, Jeffrey P Hammel, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1082: Exposure-Response Analyses of Hemoglobin Changes During Epetraborole Administration to Nonhuman Primates Predict Human Exposure-Response Relationships

2026 · Christopher M Rubino, Jeffrey P Hammel, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1041: Epetraborole Demonstrates an Exposure-Dependent Effect on Erythropoiesis in Healthy Subjects

2026 · Sanjay Chanda, Alex Smith, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MPN-1076: Hematologic and Safety Profile of Epetraborole in a Non-Polycythemia Vera Patient Population

2026 · George H Talbot, Stanton Gerson, et al. · Clinical Lymphoma Myeloma & Leukemia

1246: Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in the Inpatient Setting

2021 · Alex Smith, David Sudekum, et al. · Critical Care Medicine

5.46 NCRN CLL207 Study of Alemtuzumab Consolidation in Chronic Lymphocytic Leukaemia: Response Assessment Follow-up and Pharmacokinetic studies (on Behalf of the NCRI CLL Trials Sub-Group)

2011 · Abraham M. Varghese, Dena Cohen, et al. · Clinical Lymphoma Myeloma & Leukemia

5 - Neutrophil accumulation and bacterial clearance are delayed in patients with Crohn's disease

2009 · B. Hayee, F.Z. Rahman, et al. · Journal of Crohn s and Colitis

Works count: 16

Citation count: 141

H-index: 4

I10-index: 2